Pirtobrutinib
Specifications
2101700-15-4CAS Number
864-730-9EC Number
5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamideIUPAC Name
C22H21F4N5O3Chemical Formula
479.4 g/molMolecular Weight
Pirtobrutinib; 2101700-15-4; LOXO-305; JAYPIRCA; RXC-005; LY3527727; (S)-5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide; JNA39I7ZVB; LY-3527727; LOXO305; LOXO 305; 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamide; 1H-Pyrazole-4-carboxamide, 5-amino-3-(4-(((5-fluoro-2-methoxybenzoyl)amino)methyl)phenyl)-1-((1S)-2,2,2-trifluoro-1-methylethyl)-; 5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-((2S)-1,1,1-TRIFLUOROPROPAN-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE; 5-amino-3-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide; 5-amino-3-(4-(((5-fluoro-2-methoxybenzoyl)amino)methyl)phenyl)-1-((2S)-1,1,1-trifluoropropan-2-yl)pyrazole-4-carboxamide; RefChem:57417; BTK Inhibitor LOXO-305; RXC005; Pirtobrutinib [USAN]; 5-Amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methylethyl]-1H-pyrazole-4-carboxamide; BTK inhibitor 16; pirtobrutinibum; Y7W; MFCD34179491; UNII-JNA39I7ZVB; PIRTOBRUTINIB [INN]; PIRTOBRUTINIB [JAN]; Pirtobrutinib (LOXO-305)?; PIRTOBRUTINIB [WHO-DD]; MCL133; orb1303981; CHEMBL4650485; SCHEMBL19014257; SCHEMBL29404064; GTPL11628; REDX08608; C22H21F4N5O3; CHEBI:229212; FWZAWAUZXYCBKZ-NSHDSACASA-N; DTXSID301358726; GLXC-25733; REDX-08608; EX-A5016; BDBM50594747; NSC856803; WHO 11681; AKOS040755166; AT37544; NSC-856803; BL180882; BP-43653; MS-28909; DB-397939; HY-131328; CS-0133286; LY 3527727; T36287; LOXO-305;LY 3527727; RXC-005; 5-amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxamideSynonyms